Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. J Immunother Cancer. 2022;10(6).
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J Eur Acad Dermatol Venereol. 2020.
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Expert Opin Investig Drugs. 2019..
Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation. Cell Stem Cell. 2019;24(4):637-653.e9.
Recent advances in primary cutaneous T-cell lymphoma. Curr Opin Oncol. 2015..
Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sézary Syndrome. JAMA Dermatol. 2014.